Metabolomics based mechanistic insights to vasorelaxant and cardioprotective effect of ethanolic extract of Citrullus lanatus (Thunb.) Matsum. & Nakai. seeds in isoproterenol induced myocardial infraction

Copyright © 2022 The Author(s). Published by Elsevier GmbH.. All rights reserved..

BACKGROUND: Cardiovascular diseases (CVDs) are a significant cause of morbidity and death in the current world, posing a challenge to both developing and industrialized nation's health systems. Citrullus lanatus (Thunb.) Matsum. & Nakai. seeds have long been utilized to supplement and enhance health and treat cardiovascular illnesses. However, its treatments for CVDs are still unknown. More research is required to fully comprehend the impact of C. lanatus seeds on vasorelaxation and myocardial infractions.

PURPOSE: Therefore, an integrated metabolomics profiling technique was used to investigate possible pathways of C. lanatus in isoproterenol (ISO)-induced myocardial infarction (MI). Isoproterenol causes long-term cardiac hypertrophy by causing cardiomyocyte compensatory loss, eventually leading to heart failure.

METHODS: In vitro models of vasoconstriction, atrium, and in vivo models of invasive blood pressure measurement and isoproterenol (ISO) induced cardiac hypertrophy in rats were used to understand underlying mechanistic by LC-MS/MS based dynamic metabolomics analysis of the serum and heart samples to be investigated the effect of ethanolic extract of C. lanatus (Cl.EtOH).

RESULTS: Cl.EtOH exhibited vasorelaxant, negative chronotropic, and inotropic effects in in-vitro models whereas, a potent hypotensive effect was observed in normotensive rats. The Cl.EtOH protected the animals from ISO-induced myocardial infarction (MI) with therapeutic interventions in left ventricular thickness, cardiomyocyte hypertrophy, mRNA gene expression, biochemical assays, and metabolomic profiling of serum and heart tissues.

CONCLUSIONS: For the first time, our study confirmed that C. lanatus seeds (Cl.EtOH) possess significant antihypertensive and prevent ISO-induced myocardial infarction. These findings comprehensively demonstrated mechanistic insights of Cl.EtOH in vasorelaxation and myocardial infarction. The current study provides evidence for further mechanistic studies and the development of C. lanatus seeds as a potential therapeutic intervention for patients with cardiovascular disorders.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:100

Enthalten in:

Phytomedicine : international journal of phytotherapy and phytopharmacology - 100(2022) vom: 15. Juni, Seite 154069

Sprache:

Englisch

Beteiligte Personen:

Saqib, Fatima [VerfasserIn]
Wahid, Muqeet [VerfasserIn]
Al-Huqail, Arwa Abdulkreem [VerfasserIn]
Ahmedah, Hanadi Talal [VerfasserIn]
Bigiu, Nicusor [VerfasserIn]
Irimie, Marius [VerfasserIn]
Moga, Marius [VerfasserIn]
Marc Vlaic, Romina Alina [VerfasserIn]
Pop, Oana Lelia [VerfasserIn]
Chicea, Liana Maria [VerfasserIn]

Links:

Volltext

Themen:

3K9958V90M
Cardiac hypertrophy
Cardioprotective
Citrullus lanatus
Ethanol
Isoproterenol
Journal Article
L628TT009W
LC-ESI MS/MS
Metabolomics
Plant Extracts
Vasodilator Agents

Anmerkungen:

Date Completed 26.04.2022

Date Revised 26.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.phymed.2022.154069

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM338944672